Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1203 Inhibitors

Olr1203 inhibitors are a specialized group of chemical compounds that target the Olr1203 receptor, an olfactory receptor belonging to the G protein-coupled receptor (GPCR) family. These receptors are key players in the detection of odorant molecules and are involved in the complex processes that translate chemical signals from the environment into neural signals perceived as smells. Olr1203 inhibitors function by specifically binding to the Olr1203 receptor, blocking its interaction with natural ligands or other activating molecules. This inhibition is achieved through a range of interactions at the molecular level, including hydrogen bonding, hydrophobic interactions, and van der Waals forces, which stabilize the inhibitor within the receptor's binding site. The design and development of these inhibitors are often based on a deep understanding of the receptor's structure, which is typically elucidated through methods such as X-ray crystallography, molecular modeling, or cryo-electron microscopy. These structural insights enable the creation of inhibitors that are both highly specific to the Olr1203 receptor and capable of modulating its activity with precision.

Chemically, Olr1203 inhibitors exhibit a diverse array of structures and properties, depending on their intended interaction with the receptor. These compounds may be small molecules with a high degree of lipophilicity, which allows them to easily cross cellular membranes and access the receptor within its native environment. Alternatively, they may be larger, more complex molecules that require specialized synthesis techniques to achieve the desired binding affinity and specificity. The synthetic routes to create these inhibitors often involve multiple steps, including the formation of key functional groups that are critical for receptor binding. Once synthesized, these compounds undergo rigorous characterization using techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC) to ensure their structural integrity and purity. The ability to effectively inhibit the Olr1203 receptor provides valuable insights into the role of specific olfactory receptors in sensory perception, as well as the broader mechanisms by which GPCRs can be regulated through chemical modulation. This research contributes to a deeper understanding of the molecular basis of olfaction and the intricate processes that govern our sense of smell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
$44.00
$109.00
61
(1)

A tyrosine kinase inhibitor, potentially influencing signaling pathways that could intersect with Olr1203's presumed activities.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Dual EGFR and HER2 inhibitor, could modulate cellular pathways potentially involving Olr1203.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$127.00
$178.00
2
(1)

A VEGFR inhibitor, might impact angiogenesis and related signaling pathways, indirectly influencing Olr1203.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Targets multiple receptor tyrosine kinases, could influence various pathways potentially linked to Olr1203.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

EGFR inhibitor, could indirectly affect cellular signaling processes where Olr1203 is involved.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Another EGFR inhibitor, potentially impacting pathways that could intersect with Olr1203's function.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

JAK inhibitor, could alter JAK-STAT signaling, potentially affecting Olr1203's activities in immune signaling.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Src family kinase inhibitor, might modulate signaling pathways related to Olr1203's speculated function.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$115.00
$415.00
11
(1)

B-RAF inhibitor, potentially influencing MAPK/ERK signaling pathways linked to Olr1203.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

RAF kinase inhibitor, could alter cell signaling pathways, potentially affecting Olr1203.